Author
University of HelsinkiORCID 0000-0003-3773-7746Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Elham Gholizadeh, Uladzislau Vadadokhau, Mücahit Varlı…·Mohieddin Jafari
This study uses CoPISA and proteomics to analyze venetoclax-azacitidine response in AML cells, identifying adaptive vulnerabilities like NRP2.
Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau…·Mohieddin Jafari
This paper introduces CoPISA, a proteomics workflow that identifies combination-specific protein targets in AML, revealing conjunctional targeting mechanisms beyond classical drug synergy.
Ehsan Zangene, Elham Gholizadeh, Uladzislau Vadadokhau…·Mohieddin Jafari
CoPISA provides a proteomics dataset profiling protein solubility and stability responses to single and combined drug treatments in AML cell lines, enabling analysis of combinatorial drug effects.